CONSORT 2025声明:随机试验报告指南更新版 CONSORT 2025 Statement: Updated Guideline for Reporting Randomised Trials
背景 设计良好且执行得当的随机试验被认为是评估医疗干预措施效益最可靠的证据。然而,目前此类试验的报告质量并不理想。CONSORT声明于1996年首次发布,并提供了1份随机试验报告应包含的必备条目清单,旨在提高随机试验报告质量。该声明于2001年和2010年进行了两次更新。本文介绍最新的CONSORT 2025声明,旨在反映近期的方法学进展及终端用户的意见反馈。 方法 我们对相关文献进行了范围综述,并制定了包括CONSORT相关实证和理论证据的专用数据库,用于生成可能需要修订的清单条目列表。该列表整合了现有CONSORT扩展(不良事件、结局、非药物治疗)主要作者提供的建议、其他相关报告指南[如...
Saved in:
| Main Author: | 译者:李辉1,2,谢雪微1,3 (Translator: LI Hui1,2, XIE Xuewei1,3 ) |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Chinese Journal of Stroke
2025-05-01
|
| Series: | Zhongguo cuzhong zazhi |
| Subjects: | |
| Online Access: | https://www.chinastroke.org.cn/CN/10.3969/j.issn.1673-5765.2025.05.009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SPIRIT 2025声明:随机试验方案指南更新版 SPIRIT 2025 Statement: Updated Guideline for Protocols of Randomised Trials
by: 译者:李辉1,2,谢雪微1,3 (Translator: LI Hui1,2, XIE Xuewei1,3 )
Published: (2025-05-01) -
CONSORT 2025声明解读:患者及公众参与说明 Interpretation of the CONSORT 2025 Statement: Explanation of Patient and Public Involvement
by: 李辉1,2,谢雪微1,3 (LI Hui1,2, XIE Xuewei1,3 )
Published: (2025-05-01) -
Ethnobotanical survey and research on bsang plants in Xizang Autonomous Region
by: ZHANG Xiong1,2, FENG Haowen1,3, WANG Jin1,3, LIN Lei1,3, WANG Yuhua1*
Published: (2024-10-01) -
改变指南的力量——近20年中国缺血性脑血管病重磅临床研究 The Power of Changing Guidelines: Two Decades of Key Clinical Trials on Ischemic Cerebrovascular Disease in China
by: 谭泽锋1,徐安定2(TAN Zefeng1, XU Anding2 )
Published: (2025-05-01) -
基于患者指南的健康教育对缺血性卒中患者二级预防用药依从性的影响(Effects of Health Education Based on the Patient Version of Guidelines on Medication Compliance in Secondary Prevention among Patients with Ischemic Stroke)
by: 王瑞香1,朱思静1,梁嘉贵2,晏利姣3,蓝远霞1 (WANG Ruixiang1, ZHU Sijing1, LIANG Jiagui2, YAN Lijiao3, LAN Yuanxia1 )
Published: (2025-02-01)